The NCBO organized a Clinical Trial Ontology Workshop at the NIH in Bethesda, MD on 16-17 May. Two talks, especially, were of relevance to HL7, given HL7's influential role in the BRIDG project. The first, by Werner Ceusters, pointed to certain problems with BRIDG, which might be resolved by means of a principled ontology of the clinical trial domain.
The second, by Barry Smith, raised certain issues as to the apparent conflict between what seem to be two goals underlying BRIDG, to serve both as a descriptive representation of protocol-driven clinical research and to serve as a prescriptive standardization of such research.
BRIDG representatives at the meeting pointed to the new release of BRIDG, which is due in June 2007, and in which, we are told, some of these problems will be addressed.
skip to main |
skip to sidebar
HL7 (Health Level 7) is a collection of standards and proposals for healthcare-specific data exchange between computer applications. Considerable efforts are being invested by governments and industry to use HL7 as part of national health IT projects. Many claims are made on behalf of HL7 by its advocates. The goal of this blog is to investigate the merits of these claims, and to provide some needed independent perspective on the HL7 project.
About Me
- Barry Smith
- Barry Smith is Julian Park Distinguished Professor of Philosophy and Professor of Neurology and Computer Science in the University at Buffalo (New York, USA). He is also a Research Scientist in the New York State Center of Excellence in Bioinformatics and Life Sciences, Director of the National Center for Ontological Research (NCOR), a principal scientist of the National Center for Biomedical Ontology (NCBO) and a Coordinating Editor of the Open Biomedical Ontologies (OBO) Foundry.
No comments:
Post a Comment